Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 17/20 | 0.70 |
| ▸ | NEK2 | P51955 | 4/20 | 0.69 |
| ▸ | PLK3 | Q9H4B4 | 4/20 | 0.69 |
| ▸ | CSF1R | P07333 | 3/20 | 0.69 |
| ▸ | KDR | P35968 | 3/20 | 0.69 |
| ▸ | LIMK1 | P53667 | 3/20 | 0.69 |
| ▸ | STK3 | Q13188 | 3/20 | 0.69 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.69 |
| ▸ | BRSK1 | Q8TDC3 | 3/20 | 0.69 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.69 |
| ▸ | MAP4K5 | Q9Y4K4 | 3/20 | 0.69 |
| ▸ | PLK4 | O00444 | 2/20 | 0.69 |
| ▸ | AURKA | O14965 | 2/20 | 0.69 |
| ▸ | JAK2 | O60674 | 2/20 | 0.69 |
| ▸ | LCK | P06239 | 2/20 | 0.69 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.69 |
| ▸ | SRC | P12931 | 2/20 | 0.69 |
| ▸ | FLT1 | P17948 | 2/20 | 0.69 |
| ▸ | CDK2 | P24941 | 2/20 | 0.69 |
| ▸ | AXL | P30530 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3735507 | 0.93 | PLK1 (0.70) | PLK1NEK2PLK3CSF1RKDR | |
| SCHEMBL3736116 | 0.92 | PLK1 (0.80) | PLK1NEK2PLK3CSF1RKDR | |
| SCHEMBL3746682 | 0.90 | PLK1 (0.67) | PLK1NEK2PLK3CSF1RKDR | |
| Gsk-1030058A SCHEMBL5058261 | 0.89 | PLK1 (0.87) | PLK1NEK2PLK3CSF1RKDR | |
| SCHEMBL4404452 | 0.88 | PLK1 (0.80) | PLK1NEK2PLK3CSF1RKDR | |
| SCHEMBL5061992 | 0.88 | PLK1 (0.79) | PLK1NEK2PLK3CSF1RKDR | |
| SCHEMBL3734344 | 0.88 | PLK1 (0.66) | PLK1NEK2PLK3CSF1RKDR | |
| SCHEMBL5062408 | 0.87 | PLK1 (0.72) | PLK1NEK2PLK3CSF1RKDR | |
| SCHEMBL5062071 | 0.87 | PLK1 (0.77) | PLK1NEK2PLK3CSF1RKDR | |
| SCHEMBL3737415 | 0.86 | PLK1 (0.62) | PLK1NEK2PLK3CSF1RKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8273890-B2 | Thiophene-imidazopyridines | 4SC AG (DE) | 2012-09-25 | — | — | US | disclosed |
| US-20100278833-A1 | THIOPHENE-IMIDAZOPYRIDINES | 4SC AG (DE) | 2010-11-04 | — | — | US | disclosed |
| EP-2017277-A1 | Thiophene-imidazopyridines | 4SC AG (DE) | 2009-01-21 | — | — | EP | disclosed |
| WO-2009003911-A1 | THIOPHENE-IMIDAZOPYRIDINES | 4SC AG (DE) | 2009-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100278833-A1 | THIOPHENE-IMIDAZOPYRIDINES | PIKFYVE, PIP4K2B, PIP5K1B | PLK1 642/4885NEK2 2328/4885PLK3 1528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.